During the past decade, Vanderbilt-Ingram Cancer Center conducted 409 clinical trials. In the 10-year time frame, 409 clinical trials started and 314 clinical trials were completed, i.e. on average, 76.8% percent of trials that started reached the finish line to date. In the past 5 years, 157 clinical trials started and 154 clinical trials were completed. i.e. 98.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 216 trials, followed by "Vanderbilt-Ingram Cancer Center" with 150 trials sponsored, "Children's Oncology Group" with 145 trials sponsored, "Radiation Therapy Oncology Group" with 47 trials sponsored and "Eastern Cooperative Oncology Group" with 47 trials sponsored. Other sponsors include 435 different institutions and companies that sponsored additional 190 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 531 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Eastern Cooperative Oncology Group" with 17 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator and "Genentech, Inc." with 15 trials as a collaborator. Other collaborators include 293 different institutions and companies that were collaborators in the rest 160 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt-Ingram Cancer Center" are "Head and Neck Cancer" (60 trials), "Lung Cancer" (57 trials), "Breast Cancer" (56 trials), "Leukemia" (48 trials) and "Lymphoma" (46 trials). Many other conditions were trialed in "Vanderbilt-Ingram Cancer Center" in a lesser frequency.

Most popular intervention types in "Vanderbilt-Ingram Cancer Center" are "Drug" (771 trials), "Other" (391 trials), "Procedure" (278 trials), "Biological" (267 trials) and "Radiation" (204 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (166 trials), "radiation therapy" (74 trials), "Quality-of-Life Assessment" (67 trials), "laboratory biomarker analysis" (64 trials) and "Biospecimen Collection" (59 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt-Ingram Cancer Center" are 927 trials for "All" genders, 85 trials for "Female" genders and 28 trials for "Male" genders.

Currently, there are 378 active trials in "Vanderbilt-Ingram Cancer Center". 1 are not yet recruiting, 162 are recruiting, 214 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 515 completed trials in Vanderbilt-Ingram Cancer Center, 7 suspended trials, and 121 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt-Ingram Cancer Center, 191 "Phase 1" clinical trials were conducted, 492 "Phase 2" clinical trials and 274 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 62 trials that are defined as “Not Applicable".